• Je něco špatně v tomto záznamu ?

Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation

S. Giallongo, D. Rehakova, M. Raffaele, O. Lo Re, I. Koutna, M. Vinciguerra

. 2021 ; 34 (4) : 335-349. [pub] 20200717

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004634

Significance: Since their discovery, induced pluripotent stem cells (iPSCs) had generated considerable interest in the scientific community for their great potential in regenerative medicine, disease modeling, and cell-based therapeutic approach, due to their unique characteristics of self-renewal and pluripotency. Recent Advances: Technological advances in iPSC genome-wide epigenetic profiling led to the elucidation of the epigenetic control of cellular identity during nuclear reprogramming. Moreover, iPSC physiology and metabolism are tightly regulated by oxidation-reduction events that mainly occur during the respiratory chain. In theory, iPSC-derived differentiated cells would be ideal for stem cell transplantation as autologous cells from donors, as the risks of rejection are minimal. Critical Issues: However, iPSCs experience high oxidative stress that, in turn, confers a high risk of increased genomic instability, which is most often linked to DNA repair deficiencies. Genomic instability has to be assessed before iPSCs can be used in therapeutic designs. Future Directions: This review will particularly focus on the links between redox balance and epigenetic modifications-in particular based on the histone variant macroH2A1-that determine DNA damage response in iPSCs and derived differentiated cells, and that might be exploited to decrease the teratogenic potential on iPSC transplantation. Antioxid. Redox Signal. 34, 335-349.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004634
003      
CZ-PrNML
005      
20220127145111.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/ars.2019.7983 $2 doi
035    __
$a (PubMed)32567336
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Giallongo, Sebastiano $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation / $c S. Giallongo, D. Rehakova, M. Raffaele, O. Lo Re, I. Koutna, M. Vinciguerra
520    9_
$a Significance: Since their discovery, induced pluripotent stem cells (iPSCs) had generated considerable interest in the scientific community for their great potential in regenerative medicine, disease modeling, and cell-based therapeutic approach, due to their unique characteristics of self-renewal and pluripotency. Recent Advances: Technological advances in iPSC genome-wide epigenetic profiling led to the elucidation of the epigenetic control of cellular identity during nuclear reprogramming. Moreover, iPSC physiology and metabolism are tightly regulated by oxidation-reduction events that mainly occur during the respiratory chain. In theory, iPSC-derived differentiated cells would be ideal for stem cell transplantation as autologous cells from donors, as the risks of rejection are minimal. Critical Issues: However, iPSCs experience high oxidative stress that, in turn, confers a high risk of increased genomic instability, which is most often linked to DNA repair deficiencies. Genomic instability has to be assessed before iPSCs can be used in therapeutic designs. Future Directions: This review will particularly focus on the links between redox balance and epigenetic modifications-in particular based on the histone variant macroH2A1-that determine DNA damage response in iPSCs and derived differentiated cells, and that might be exploited to decrease the teratogenic potential on iPSC transplantation. Antioxid. Redox Signal. 34, 335-349.
650    12
$a buněčná diferenciace $x genetika $7 D002454
650    _2
$a buněčná sebeobnova $7 D000066673
650    _2
$a nádorová transformace buněk $x genetika $x metabolismus $7 D002471
650    _2
$a přeprogramování buněk $x genetika $7 D065150
650    _2
$a metylace DNA $7 D019175
650    12
$a epigeneze genetická $7 D044127
650    _2
$a nestabilita genomu $7 D042822
650    _2
$a lidé $7 D006801
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $x metabolismus $7 D057026
650    _2
$a mitochondrie $x genetika $x metabolismus $7 D008928
650    12
$a oxidace-redukce $7 D010084
650    _2
$a oxidativní fosforylace $7 D010085
650    _2
$a oxidační stres $7 D018384
650    _2
$a pluripotentní kmenové buňky $x cytologie $x metabolismus $7 D039904
650    _2
$a regenerativní lékařství $7 D044968
650    _2
$a transplantace kmenových buněk $7 D033581
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rehakova, Daniela $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic $u Faculty of Informatics, Centre for Biomedical Image Analysis, Masaryk University, Brno, Czech Republic
700    1_
$a Raffaele, Marco $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic
700    1_
$a Lo Re, Oriana $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic
700    1_
$a Koutna, Irena $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic $u Faculty of Informatics, Centre for Biomedical Image Analysis, Masaryk University, Brno, Czech Republic
700    1_
$a Vinciguerra, Manlio $u International Clinical Research Center, St' Anne's University Hospital, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00006026 $t Antioxidants & redox signaling $x 1557-7716 $g Roč. 34, č. 4 (2021), s. 335-349
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32567336 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145108 $b ABA008
999    __
$a ok $b bmc $g 1751943 $s 1155783
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 34 $c 4 $d 335-349 $e 20200717 $i 1557-7716 $m Antioxidants & redox signaling $n Antioxid Redox Signal $x MED00006026
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace